| Financial Year |
March 31 2023 |
| Monetary Funds |
73,912,959.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
23,401,858.26 |
| Accounts Receivable |
136,802,036.10 |
| Advances to Suppliers |
16,210,566.26 |
| Other Receivables |
49,853,490.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
238,135,293.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,774,381.71 |
| Total Current Assets |
545,090,585.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
115,351,767.48 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
794,896,226.06 |
| Under-construction Projects |
525,538,657.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,133,179.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
22,552,801.89 |
| Other Non-Current Assets |
63,687,967.24 |
| Sub-Total of Non-Current Assets |
1,664,461,579.76 |
| Total Assets |
2,209,552,165.37 |
| Short-Term Loans |
608,936,606.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,504,000.00 |
| Accounts Payable |
268,732,709.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,475,349.04 |
| Taxes Payable |
9,851,065.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
756,736,441.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,417,803.21 |
| Other Current Liabilities |
21,795,997.39 |
| Sub-Total of Current Liabilities |
1,726,790,990.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,220,664.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,909,664.99 |
| Total Liabilities |
1,735,700,655.40 |
| Paid-In Capital(Or Share Stock) |
319,948,070.00 |
| Capital Surplus |
603,412,920.49 |
| Surplus Reserve |
31,863,939.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-478,166,857.58 |
| Minority Stockholder's Interest |
-3,206,562.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
477,058,072.13 |
| Owner's Equity（Stockholder's Equity） |
473,851,509.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,209,552,165.37 |
